首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Canadian journal of gastroenterology

缩写:

ISSN:2291-2789

e-ISSN:2291-2797

IF/分区:2.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引920
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hannah M Brinkman,Kianoush B Kashani,Alice Gallo de Moraes et al. Hannah M Brinkman et al.
Background: The choice of resuscitation fluid remains debated for patients with septic shock. While patients with cirrhosis may benefit from albumin administration, the efficacy of albumin for resuscitation in cirrhotic patients with septic...
Omaira Valencia,Carolina López,Esteban Vanegas-Duarte et al. Omaira Valencia et al.
Background: Nonalcoholic fatty liver disease (NAFLD) has a major impact on public health owing to its high morbidity and mortality due to its close relationship with several conditions, including metabolic syndrome, cirrhosis, and cancer. T...
Su Hyun Park,Oh Young Lee,Yong Chan Lee et al. Su Hyun Park et al.
CKD-495 is a newly developed drug extracted from Cinnamomum cassia Presl. This phase II study assessed the clinical benefits of CKD-495 in the treatment of acute and chronic gastritis. This study randomly assigned 250 patients with endoscop...
Yuting Diao,Yueying Zeng,Zhihao Huang et al. Yuting Diao et al.
Background and objectives: The efficacy of antiviral therapy in chronic hepatitis B (CHB) patients with normal alanine aminotransferase (ALT) is controversial. This study aimed to systematically review and analyze antiviral efficacy in ALT-...
Manisha Jogendran,Louis Huynh,Jennifer A Flemming Manisha Jogendran
Introduction: Alcohol-associated liver disease (ALD) is one of the most common causes of cirrhosis. Pharmacotherapy for alcohol use disorder (AUD) can improve abstinence rates in patients with cirrhosis, however, there is limited data on ho...
Haoxuan Zou,Jiejie Xie,Xiaopu Ma et al. Haoxuan Zou et al.
Background: Triglyceride glucose (TyG) and its related index (TyG-body mass index, TyG-BMI) are recognized as markers for nonalcoholic fatty liver disease (NAFLD), but their associations with metabolic dysfunction-associated steatotic liver...
Fannie Lajeunesse-Trempe,Selena Dugas,Ina Maltais-Payette et al. Fannie Lajeunesse-Trempe et al.
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is highly prevalent among people living with severe obesity (body mass index [BMI] ≥ 35 kg/m2). However, it remains unknown how sex and adipose tissue distribution ...
David C Sealey,Kai Fai Ho,Z Christina Zhou et al. David C Sealey et al.
Background: Although it is generally believed that infliximab dose optimization in patients with inflammatory bowel disease with low serum infliximab concentration at trough results in increased treatment persistence, empirical data to supp...
Sai Zhao,Xue Yang,Yu He et al. Sai Zhao et al.
Background: Aims: Carboxylesterase (Ces)1f is implicated in protection against hepatic inflammation, but it is unclear whether the enzyme has an influence in polarization of Kupffer cells (KCs), the innate immune cells mediating hepatic inf...